Quest Diagnostics Incorporated (DGX)

USD 151.25

(-2.73%)

Market Cap (In USD)

16.88 Billion

Revenue (In USD)

9.25 Billion

Net Income (In USD)

854 Million

Avg. Volume

845.31 Thousand

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
123.04-165.32
PE
-
EPS
-
Beta Value
0.891
ISIN
US74834L1008
CUSIP
74834L100
CIK
1022079
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Mr. James E. Davis
Employee Count
-
Website
https://www.questdiagnostics.com
Ipo Date
1996-12-17
Details
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.